In this trial, we are evaluating the safety and tolerability of a needle-free investigational DNA vaccine to protect against SARS CoV-2 virus. Despite recent vaccines being approved for use, development of new technologies and “next generation” investigational vaccines are still being tested. If you are a healthy adult this is an opportunity for you to participate in this global effort.
This potential next-generation vaccine has no additives or preservatives. It will be given using a needle-free device that penetrates the skin with a jet spray and is designed to make sure the vaccine gets inside the cells to encourage good uptake by the immune system.
Co-Investigator Professor Peter Richmond from the Telethon Kids Institute said, “It is really important that we continue to develop the next generation of COVID-19 vaccines, as we may see even better safety and immune responses. Having a greater range of vaccines available increases global vaccine capacity to ensure everyone has access to immunisation.”
This study will require 8 clinic visits and 2 telephone calls over a twelve month period.
To be eligible you can not have had a COVID-19 vaccine and must be: